Cytokinetics | CYTK - Actif À Court Terme





Actif À Court Terme Changement Date
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Amgen USD 34.96B 3.49B 2026-06
Arca Biopharma USD 395.25M 51.39M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Biogen USD 7.31B 1.88B 2026-06
Brainstorm Cell Therapeutics USD 184K 123K 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Capricor Therapeutics USD 283.09M 39.85M 2026-03
Cytokinetics USD 1.21B 369.02M 2026-06
Eisai JPY 883.01B 121.38B 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Exelixis USD 1.21B 234.65M 2026-03
Geron USD 486.34M 12.19M 2026-06
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
Merck USD 36.68B 1.66B 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06